Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Head and Neck Cancer

Free Subscription 07.10.2019 1 Anticancer Res 1 Br J Oral Maxillofac Surg 1 Cancer 2 Clin Cancer Res 4 Clin Nucl Med 5 Head Neck 2 Int J Radiat Oncol Biol Phys 1 Laryngoscope 3 Oral Oncol 2 PLoS One 2 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Anticancer Res

1. GUO JC, Lin CC, Lin CY, Hsieh MS, et al
   Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
   Anticancer Res. 2019;39:5675-5682.
   PubMed     Text format     Abstract available
   
   

   
   Br J Oral Maxillofac Surg

2. KAURA A, Kennedy RA, Ali S, Odell E, et al
   Utility of neck dissection for management of carcinoma of the parotid gland.
   Br J Oral Maxillofac Surg. 2019 Sep 26. pii: S0266-4356(19)30350.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

3. NOCON CC, Ajmani GS, Bhayani MK
   A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer.
   Cancer. 2019 Oct 3. doi: 10.1002/cncr.32342.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

4. HANNA GJ, Busaidy NL, Chau NG, Wirth LJ, et al
   Genomic correlates of response to everolimus in aggressive radioiodine-refractory thyroid cancer: a phase II study.
   Clin Cancer Res. 2018 Jan 4. pii: 1078-0432.CCR-17-2297.
   PubMed     Text format     Abstract available
   
   
5. ZHOU L, Mudianto T, Ma X, Riley R, et al
   Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancers.
   Clin Cancer Res. 2019 Sep 27. pii: 1078-0432.CCR-19-1351.
   PubMed     Text format     Abstract available
   
   

   
   Clin Nucl Med

6. SON SH, Lee CH, Jung JH, Kim DH, et al
   The Preventive Effect of Parotid Gland Massage on Salivary Gland Dysfunction During High-Dose Radioactive Iodine Therapy for Differentiated Thyroid Cancer: A Randomized Clinical Trial.
   Clin Nucl Med. 2019;44:625-633.
   PubMed     Text format     Abstract available
   
   
7. KONDRACIUK JD, Rice SL, Zhou X, Gharzeddine K, et al
   Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.
   Clin Nucl Med. 2019;44:e465-e471.
   PubMed     Text format     Abstract available
   
   
8. TRIPATHY S, Kumar R, Kakkar A, Kumar R, et al
   Esthesioneuroblastoma on 68Ga DOTANOC PET/CT.
   Clin Nucl Med. 2019;44:e486-e488.
   PubMed     Text format     Abstract available
   
   
9. LIU L, Chen Y, Tian T, Huang R, et al
   An Unusual False-Positive Uptake of Radioiodine Caused by Metallic Implants.
   Clin Nucl Med. 2019;44:e495-e496.
   PubMed     Text format     Abstract available
   
   

   
   Head Neck

10. NISHIO N, van Keulen S, van den Berg NS, Lu G, et al
    Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
    Head Neck. 2019 Oct 1. doi: 10.1002/hed.25964.
    PubMed     Text format     Abstract available
    
    
11. HSIEH JC, Wang HM, Wu MH, Chang KP, et al
    Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy.
    Head Neck. 2019;41 Suppl 1:19-45.
    PubMed     Text format     Abstract available
    
    
12. CHEN TH, Chang PM, Yang MH
    Novel immune-modulating drugs for advanced head and neck cancer.
    Head Neck. 2019;41 Suppl 1:46-56.
    PubMed     Text format     Abstract available
    
    
13. LOU PJ
    Preface for the special issue of "Immunotherapy for head and neck cancers: Current landscapes, emerging biomarkers, and future directions".
    Head Neck. 2019;41 Suppl 1:3.
    PubMed     Text format    
    
    
14. KAO HF, Lou PJ
    Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.
    Head Neck. 2019;41 Suppl 1:4-18.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

15. VITZTHUM LK, Park H, Zakeri K, Bryant AK, et al
    Selection of Head and Neck Cancer Patients for Intensive Therapy.
    Int J Radiat Oncol Biol Phys. 2019 Sep 30. pii: S0360-3016(19)33835.
    PubMed     Text format     Abstract available
    
    
16. SO N, McDowell LJ, Lu L, Xu W, et al
    The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
    Int J Radiat Oncol Biol Phys. 2019 Sep 27. pii: S0360-3016(19)33828.
    PubMed     Text format     Abstract available
    
    

    
    Laryngoscope

17. MCHUGH T, Zhang H, Xie M, Gupta MK, et al
    Elevated troponin: A marker for noncardiac complications after resection of head and neck cancers.
    Laryngoscope. 2019 Sep 30. doi: 10.1002/lary.28291.
    PubMed     Text format     Abstract available
    
    

    
    Oral Oncol

18. HAAPANIEMI A, Makitie A, Kekolahti P, Ryynanen OP, et al
    A preliminary Bayesian network model to identify factors associated with treatment outcome in T2 and T3 laryngeal carcinoma.
    Oral Oncol. 2019 Sep 25. pii: S1368-8375(19)30306.
    PubMed     Text format    
    
    
19. YANG K, Tian J, Zhang B, Li M, et al
    A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2019;98:85-91.
    PubMed     Text format     Abstract available
    
    
20. LI M, Chen H, Wu T
    LIN28: A cancer stem cell promoter for immunotherapy in head and neck squamous cell carcinoma.
    Oral Oncol. 2019;98:92-95.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

21. GOMEZ-ARMAYONES S, Chimenos-Kustner E, Mari A, Tous S, et al
    Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort.
    PLoS One. 2019;14:e0210070.
    PubMed     Text format     Abstract available
    
    
22. HUANG YC, Li SH, Lu HI, Hsu CC, et al
    Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma.
    PLoS One. 2019;14:e0210055.
    PubMed     Text format     Abstract available
    
    

    
    Radiother Oncol

23. YANG Z, Zhang X, Wang X, Zhu XR, et al
    Multiple-CT optimization: An adaptive optimization method to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers.
    Radiother Oncol. 2019 Sep 26. pii: S0167-8140(19)33094.
    PubMed     Text format     Abstract available
    
    
24. ELBERS JBW, Al-Mamgani A, Tesseslaar MET, van den Brekel MWM, et al
    Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial.
    Radiother Oncol. 2019 Sep 26. pii: S0167-8140(19)33046.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: